Medicare utilization — NANCY FELTY MORIN (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 11,250 | 11 | $0 | $9,739 |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 910 | 15 | $0 | $5,631 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 481 | 289 | $0 | $40,674 |
| 96361 | Infusion into a vein for hydration, each additional hour | 446 | 38 | $0 | $4,489 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 145 | 37 | $0 | $150 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·